Market Place
Sourcing Support
AbbVie & Gedeon Announce Collaboration For Neuropsychiatric Targets
24 Oct 2024 //
PR NEWSWIRE
Mithra In Exclusive Talks With Richter, Secures Funding
03 May 2024 //
GLOBENEWSWIRE
Gedeon Richter: Cariprazine Poised for Success
10 Apr 2024 //
PR NEWSWIRE
Gedeon Richter Selects Trial Interactive for Clinical Trial Management
25 Mar 2024 //
PR NEWSWIRE
Gedeon`s Ryeqo (Relugolix) Receives Approval in Europe
08 Jun 2023 //
EMA
NICE draft final guidance for Gedeon Richter UK’s new uterine fibroids treatment
13 May 2022 //
PHARMATIMES
AbbVie and Gedeon Richter Enter Co-Development and License Agreement
12 Mar 2022 //
CONTRACTPHARMA
Richter, Hikma sign excl. commercialisation & license agreement for denosumab
09 Dec 2021 //
PRNEWSWIRE
Gedeon Richter receives licence for IUS for contraception in the UK
03 Nov 2021 //
FIRSTWORDPHARMA
Gedeon Richter`s Ryeqo Receives Approval in Europe
29 Jul 2021 //
EMA
Myovant, Gedeon Richter’s uterine fibroids med Ryeqo bags EU approval
20 Jul 2021 //
PHARMATIMES
Mycovia Pharmaceuticals Announces Partnership with Gedeon Richter
16 Oct 2019 //
BUSINESSWIRE
Gedeon Richter`s Ulipristal Acetate Receives Marketing Approval in Europe
06 Sep 2018 //
EMA
Gedeon Richter Plc`s Generic Ulipristal Acetate Receives Approval in Europe
04 Jul 2018 //
EMA
Gedeon’s re-filed Neulasta biosimilar under EU review
07 Mar 2018 //
PHARMA TIMES
EU nod for Gedeon’s novel antipsychotic Reagila
19 Jul 2017 //
PHARMA TIMES
Astellas and Gedeon Richter breach ABPI code
09 Jun 2017 //
THE PHARMALETTER
Astellas and Gedeon named for ABPI Code breaches
08 Jun 2017 //
PHARMA TIMES
Gedeon Richter Plc Terrosa (teriparatide) Receives Approval In Europe
05 May 2017 //
EMA
Gedeon Richter Terrosa (Teriparatide) Receives Approval In Europe
16 Mar 2017 //
EMA
Allergan, Gedeon report positive results from phIII trial of ulipristal acetate
17 Jan 2017 //
PHARMABIZ
Nine Therapies Put Forward for EU Approval
15 Nov 2016 //
PHARMATIMES
Richter`s generic osteoporosis drug gets EU recommendation
14 Nov 2016 //
REUTERS
Statin APIs from Gedeon Richterlinked firm should prohibited say GMP inspectors
16 Aug 2016 //
IN PHARMATECHNOLOGIST
Allergan and Richter Provide Update on Cariprazine Program
05 Aug 2016 //
PR NEWSWIRE
Allergan, Richter Announce Positive PhIII Result for Ulipristal Acetate 5/10 mg
10 May 2016 //
PR NEWSWIRE
SMC allows wider use of Gedeon Richter`s Esmya
23 Mar 2016 //
PHARMATIMES
In Addyi`s shadow, Richter walks away from a female libido drug
22 Sep 2015 //
FIERCE BIOTECH
Richter`s New Drug Take Years to Offset Russia
21 Sep 2015 //
BLOOMBERG BUSINESS
Allergan and Richter`s antipsychotic gets FDA OK but faces stiff competition
19 Sep 2015 //
FIERCE PHARMA
US extends review of Allergan/Gedeon Richter`s antipsychotic
17 Jun 2015 //
PHARMA TIMES
Palatin Announces Start of Bremelanotide Phase 3 Program For Female Sexual Dysfunction
29 Dec 2014 //
PALATIN TECHNOLOGIES
